Literature DB >> 2712272

Attenuation of electroconvulsive therapy induced hypertension with sublingual nifedipine.

D G Wells1, G G Davies, F Rosewarne.   

Abstract

Five patients known to be previously hypertensive but not currently receiving anti-hypertensive medications were studied for a total of twenty-six administrations of electroconvulsive therapy. Patients randomly received sublingual nifedipine 10 mg, 20 minutes prior to half of their treatments, and for the remaining treatments acted as their own controls. The use of nifedipine resulted in significant attenuation of the blood pressure response to therapy. Systolic pressure increase was 24 mmHg (SD 14) versus 62 mmHg (SD 24) (P less than 0.01). There was no difference in heart rate between the two groups. It is concluded that nifedipine reduces the pressor response to electroconvulsive therapy in individuals with a history of hypertension.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2712272     DOI: 10.1177/0310057X8901700107

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  4 in total

Review 1.  Guide to anaesthetic selection for electroconvulsive therapy.

Authors:  Klaus J Wagner; Oliver Möllenberg; Michael Rentrop; Christian Werner; Eberhard F Kochs
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  Comparative tolerability profile of hypertensive crisis treatments.

Authors:  E Grossman; A N Ironi; F H Messerli
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

3.  Effectiveness of dexmedetomidine as premedication prior to electroconvulsive therapy, a Randomized controlled cross over study.

Authors:  Deepa Sannakki; Naina Parag Dalvi; Shilpa Sannakki; Devangi P Parikh; Sanchita K Garg; Bharati Tendolkar
Journal:  Indian J Psychiatry       Date:  2017 Jul-Sep       Impact factor: 1.759

4.  The effects of hyperventilation on seizure length and cerebral oxygenation during electroconvulsive therapy.

Authors:  Oguz Gundogdu; Onur Avci; Sinan Gursoy; Kenan Kaygusuz; Iclal Ozdemir Kol
Journal:  North Clin Istanb       Date:  2020-04-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.